Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

被引:93
|
作者
Schmidt, Morten [1 ]
Lamberts, Morten [2 ]
Olsen, Anne-Marie Schjerning [2 ]
Fosboll, Emil [3 ]
Niessner, Alexander [4 ]
Tamargo, Juan [5 ]
Rosano, Giuseppe [6 ,7 ]
Agewall, Stefan [8 ,9 ]
Kaski, Juan Carlos [10 ]
Kjeldsen, Keld [11 ,12 ,13 ]
Lewis, Basil S. [14 ]
Torp-Pedersen, Christian [15 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus, Denmark
[2] Copenhagen Univ Hosp, Dept Cardiol, Hellerup, Denmark
[3] Rigshosp, Copenhagen Univ Hosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria
[5] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain
[6] IRCCS San Raffaele Roma, Rome, Italy
[7] St George Hosp, Cardiovasc & Cell Sci Inst, London, England
[8] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway
[9] Univ Oslo, Inst Clin Med, Oslo, Norway
[10] Univ London, St Georges, Div Cardiac & Vasc Sci, London, England
[11] Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark
[12] Holbaek Cent Hosp, Holbaek, Denmark
[13] Aalborg Univ, Fac Med, Aalborg, Denmark
[14] Technion Israel Inst Technol, Lady Davis Carmel Med Ctr, Ruth & Bruce Rappaport Sch Med, Tel Aviv, Israel
[15] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark
关键词
RECEIVING ANTITHROMBOTIC THERAPY; CYCLOOXYGENASE-2; INHIBITORS; MYOCARDIAL-INFARCTION; GASTROINTESTINAL TOXICITY; SELECTIVE INHIBITORS; ATRIAL-FIBRILLATION; DOUBLE-BLIND; RISK; EVENTS; METAANALYSIS;
D O I
10.1093/eurheartj/ehv505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1015 / U26
页数:11
相关论文
共 50 条
  • [1] Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Schmidt, Morten
    Lamberts, Morten
    Olsen, Anne-Marie Schjerning
    Fosboll, Emil
    Niessner, Alexander
    Tamargo, Juan
    Rosano, Giuseppe
    Agewall, Stefan
    Kaski, Juan Carlos
    Kjeldsen, Keld
    Lewis, Basil S.
    Torp-Pedersen, Christian
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (02) : 108 - 118
  • [2] Cardiovascular risks associated with non-aspirin non-steroidal anti-inflammatory drug use
    Schmidt, Morten
    DANISH MEDICAL JOURNAL, 2015, 62 (03):
  • [3] Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited
    Walker, Chris
    Biasucci, Luigi M.
    POSTGRADUATE MEDICINE, 2018, 130 (01) : 55 - 71
  • [4] Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies
    Zaman, Farzana Y.
    Orchard, Suzanne G.
    Haydon, Andrew
    Zalcberg, John R.
    BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1735 - 1743
  • [5] Cardiovascular risk of non-steroidal anti-inflammatory drugs
    Prozzi, Guillermo R.
    Canas, Martin
    Urtasun, Martin A.
    Buschiazzo, Hector O.
    Dorati, Cristian M.
    Mordujovich-Buschiazzo, Perla
    MEDICINA-BUENOS AIRES, 2018, 78 (05) : 349 - 355
  • [6] Review: Cardiovascular complications of non-steroidal anti-inflammatory drugs
    Fosslien, E
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (04) : 347 - 385
  • [7] Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Niessner, Alexander
    Tamargo, Juan
    Koller, Lorenz
    Saely, Christoph H.
    Schmidt, Thomas Andersen
    Savarese, Gianluigi
    Wassmann, Sven
    Rosano, Giuseppe
    Ceconi, Claudio
    Torp-Pedersen, Christian
    Kaski, Juan Carlos
    Kjeldsen, Keld Per
    Agewall, Stefan
    Walther, Thomas
    Drexel, Heinz
    Lewis, Basil S.
    EUROPEAN HEART JOURNAL, 2018, 39 (24) : 2274 - 2281
  • [8] Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
    Trelle, Sven
    Reichenbach, Stephan
    Wandel, Simon
    Hildebrand, Pius
    Tschannen, Beatrice
    Villiger, Peter M.
    Egger, Matthias
    Jueni, Peter
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342 : 154
  • [9] Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals
    Fosbol, Emil Loldrup
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (06) : 893 - 903
  • [10] Genetic Polymorphisms and the Cardiovascular Risk of Non-Steroidal Anti-Inflammatory Drugs
    St Germaine, Christine G.
    Bogaty, Peter
    Boyer, Luce
    Hanley, James
    Engert, James C.
    Brophy, James M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (12) : 1740 - 1745